LILLIAN KATZ: Open Payments
NPI 1679768097 · JAMESBURG, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 71 payments from 22 companies in 2025. Trend: 2023 $303 · 2024 $1,095 · 2025 $1,397
Food & beverage: $1,307Education: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 14 | $194 |
| AstraZeneca Pharmaceuticals LP | 7 | $189 |
| GENZYME CORPORATION | 8 | $174 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Madrigal Pharmaceuticals | 3 | $76 |
| Viatris Specialty LLC | 4 | $68 |
| Exact Sciences Corporation | 3 | $67 |
| Insmed, Inc. | 4 | $67 |
| Amgen Inc. | 4 | $62 |
| Abbott Laboratories | 3 | $60 |
Products named: DUPIXENT, NUCALA, BREZTRI, TRELEGY ELLIPTA, REZDIFFRA, YUPELRI, Arikayce, TEZSPIRE.
Industry payments across NJ — which companies pay providers there.
